November 19–22, 2024 – ROYAL Pharm presented a range of innovative pharmaceutical products at PharmaTech 2024, a premier international exhibition for pharmaceutical technology. As one of the key events in the global pharma industry, the exhibition gathered leading pharmaceutical companies, technology providers, and industry experts from around the world. Leveraging its strong R&D capabilities and high-quality products, ROYAL Pharm attracted significant attention from professional visitors and potential partners.During the event, the company highlighted its core competencies in API and intermediate production, premix R&D, and CMO/CDMO technology transfer, while sharing several innovative solutions and successful project cases. The on-site team provided detailed product demonstrations and technical consultations, earning widespread recognition from attendees.

One of the major highlights of the exhibition was the presentation of Semaglutide. As a globally recognized molecule in metabolic therapy, ROYAL Pharm showcased its advanced technology and rigorous quality control system in Semaglutide development and manufacturing. Through precise process control and comprehensive testing, the company ensures that its products meet international standards for safety, stability, and efficacy, gaining strong trust and interest from customers.

• Website: https://www.jlpharms.com/
• Tel: 0086-571-85829053
• Fax: 0086-571-85829153
• Address: Room 1702, 17F, Building 3, Central Plaza, No. 98 Daguang Road, Hangzhou, Zhejiang, China